ACVR2B ACE-031 Nouveaux Peptides Switzerland
Presentation: ACE-031 10 mg/cartige
BPC-157 Nouveaux Peptides Switzerland
Presentation:Â BPC-157 20mg/cartige
CJC-1295 NouVeaux Peptides (Switzerland)
Presentation: CJC-1295Â 10mg/cartige
CJC-1295 with DAC Nouveaux Peptides Switzerland
Presentation: CJC-1295 with DAC 10mg/cartige
Follistatin 344 Nouveaux Peptides Switzerland
Presentation: Follistatin 344 2mg/cartige
GHRP-2 & CJC-1295 Combo Nouveaux Peptides Switzerland
Presentation:Â 5mg GHRP-2 + 5mg CJC-1295 in each cartige)
GHRP-2 Nouveaux Switzerland
Presentation:Â GHRP-2 10mg/cartige
GHRP-6 & CJC-1295 Combo Nouveaux Peptides Switzerland
Presentation:Â (5mg GHRP-6 + 5mg CJC-1295 in each cartige)
GHRP-6 Nouveaux Switzerland
Presentation: GHRP-6Â 10mg/cartige
Hexarelin Nouveaux Peptides Switzerland
Presentation: Hexarelin 10 mg/cartige
HGH Fragment (176-191) 10mg/cartige Nouveaux Switzerland
Presentation: HGH Fragment 10mg/cartige
IFG-1 LR3 Nouveaux Peptides Switzerland
Presentation: IGF-1 LR3 1mg/cartige
Nouveaux Peptide – Innovative Peptide Solutions
Nouveaux Peptide develops and manufactures high-quality peptide-based pharmaceutical and research products. The company emphasizes precision, consistency, and strict quality standards across all its formulations.
Its portfolio includes a variety of research peptides and specialized formulations, designed to meet scientific and medical research needs. Nouveaux Peptide combines advanced production techniques with careful quality control to deliver reliable and reproducible results. Recognized in the global peptide and biotechnology market, the company is known for innovation, safety, and dependable product performance.











